Clinical observation of azithromycin sequential therapy for Mycoplasma pneumoniae pneumonia in children
Objective To compare the clinical efficacy of azithromycin sequential therapy for Mycoplasma pneumoniae pneumonia(MPP)in children.Methods A total of 60 children with MPP were randomly divided into an observation group and a control group,with 30 cases in each group.Children in both groups received symptomatic support treatment such as cough relief,phlegm reduction and fever reduction.On this basis,the observation group received azithromycin sequential therapy,and the control group received conventional treatment.The hospitalization time,rales disappearance time,fever reduction time,cough disappearance time and clinical efficacy of the two groups were compared.Results In the observation group,the hospitalization time was(9.29±2.23)d,the rale disappearance time was(2.09±0.23)d,the fever reduction time was(1.13±0.35)d,and the cough disappearance time was(5.29±0.19)d,which were significantly shorter than(15.33±3.19),(6.53±2.19),(3.79±0.93),and(7.53±1.36)d in the control group,and the difference was statistically significant(P<0.05).The total effective rate of the observation group was 96.67%,which was higher than 73.33%of the control group,and the difference was statistically significant(P<0.05).Conclusion Azithromycin sequential therapy showed obvious clinical efficacy in the treatment of MPP in children,which could significantly shorten hospitalization time and improve clinical symptoms.Therefore,azithromycin sequential therapy has potential clinical application value in the treatment of MPP in children.
AzithromycinMycoplasma pneumoniae pneumonia in childrenSequential therapy
NETL
NSTL
万方数据
